Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
02/2011
02/17/2011WO2011017800A1 Methods, compounds, and compositions for delivering 1,3-propan ed isulfonic acid
02/17/2011WO2010118291A3 Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor
02/17/2011US20110039926 Use of enantiomer (1s, 2r) milnacipran hydrochloride for the preventive treatment of suicidal behaviour in depressed patients
02/17/2011US20110039899 Gabapentin for the Treatment of Overactive Bladder, Stress Incontinence and BPH
02/17/2011US20110039892 Iminopyridine derivative and use thereof
02/17/2011US20110039877 Use of 3, 11b-cis-dihydrotetrabenazine in the treatment of multiple sclerosis and autoimmune myelitis
02/17/2011US20110039869 Composition for inhibiting the activity of inositol 1,4,5-triphosphate receptor subtype iii
02/17/2011US20110039861 Cyclic azaindole-3-carboxamides, their preparation and their use as pharmaceuticals
02/17/2011US20110039846 Iminopyridine derivatives and use thereof
02/17/2011US20110039839 Cyanopyrroles
02/17/2011US20110039830 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals
02/17/2011US20110039800 Prolonged release bioadhesive therapeutic systems
02/17/2011US20110039787 Compositions, kits and methods for treating benign prostate hyperplasia
02/17/2011US20110039782 Soybean protein material for patients with renal disease and foods made from the same
02/17/2011US20110038913 Polymeric endoprostheses with modified erosion rates and methods of manufacture
02/17/2011US20110038896 Biodegradable immunomodulatory formulations and methods for use thereof
02/17/2011CA2768877A1 Methods, compounds, and compositions for delivering 1,3-propanedisulfonic acid
02/16/2011EP2284189A2 Nucleic acid molecules encoding fibroblast growth factor-like (FGF-like) polypeptides
02/16/2011EP2284149A1 Selective androgen receptor modulators and methods of use thereof
02/16/2011EP2283867A2 Methods of treatment using anti-ERBB antibody-maytansinoid conjugates
02/16/2011EP2283866A2 Methods of treatment using anti-ERBB antibody-maytansinoid conjugates
02/16/2011EP1469077B1 Cell-specific expression/replication vector
02/16/2011EP1424080B1 Gnrh agonist combination drugs
02/16/2011CN1814193B Chinese medicine composition for treating nephritis dropsy and preparation method thereof
02/16/2011CN101977615A Inhibitor for blood phosphorus level elevation
02/16/2011CN101974395A Powerful antifatigue super oxide dismutase (SOD) health wine and preparation method thereof
02/16/2011CN101974073A Anti-inflammatory hexapeptide
02/16/2011CN101974068A Tanshinon IIA crylic acid or sodium salt thereof, preparation method and application thereof
02/16/2011CN101973998A Pyrrolopyrimidine A2b selective antagonist compounds, their synthesis and use
02/16/2011CN101973868A Sodium phenylbutyrate crystal I and preparation method thereof
02/16/2011CN101972426A Traditional Chinese medicine for treating chronic prostatitis
02/16/2011CN101972402A Chinese medicament for treating prostatitis
02/16/2011CN101972363A Healthy tea for treating prostatitis
02/16/2011CN101972352A Traditional Chinese medicine for treating diabetic nephropathy
02/16/2011CN101972349A Traditional Chinese medicine for treating benign prostatic hyperplasia
02/16/2011CN101972348A Method for extracting total saponin from leaves of rehmannia
02/16/2011CN101972345A Traditional Chinese medicine for treating chronic prostatitis
02/16/2011CN101972333A Medicament for eliminating turbid urines and activating blood stasis
02/16/2011CN101972323A Quality analysis method for loins-strengthening and kidney-invigorating oral liquid
02/16/2011CN101972320A Method for extracting ferulic acid, chlorogenic acid and other aicd components from coptis chinensis franch
02/16/2011CN101972298A Effective part of a traditional Chinese medicine for treating HBV-GN and preparation method of Chinese medicinal preparation
02/16/2011CN101972295A Method for extracting total flavonoids and total lignans from sagina subulata
02/16/2011CN101972294A New usage of eucommia ulmoides chemical composition as vessel protective agent
02/16/2011CN101972241A Application of composition containing 2-(3,4-dihydroxyphenyl) ethanol or glycoside thereof in preparing skin-whitening composition
02/16/2011CN101972238A Prescription of phenazopyridine hydrochloride capsule and preparation process
02/16/2011CN101711780B Decoction for treating renal calculus and urethral calculus
02/16/2011CN101700327B Drug for treating prostatitis and preparation method
02/16/2011CN101569694B Chinese medicinal preparation for treating pathogen infection of male and female urogenital system
02/16/2011CN101461841B Chinese patent medicine for treating prostatoplasia
02/16/2011CN101417040B Traditional Chinese medicine decoction for reinforcing kidney to replenish kidney essence
02/16/2011CN101391062B Traditional Chinese medicine preparation for treating nephritis
02/16/2011CN101209262B Use of medicine for preparing medicine for treating prostatitis
02/15/2011US7888487 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same
02/15/2011US7888458 Diagnostics and therapy of epstein-barr virus in autoimmune disorders
02/15/2011US7888348 7-membered ring compound and method of production and pharmaceutical application thereof
02/15/2011US7887804 Methods for treating disease-states associated with RG1 using immunoconjugates
02/15/2011US7887799 Antibodies to fibroblast growth factor-like polypeptides
02/15/2011US7887795 processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient; making an enhanced, autologous fat graft comprising supplementing a first portion of extracted adipose tissue with an additive and a disaggregated population of adipose-derived cells
02/15/2011CA2558272C Pyridone derivative
02/15/2011CA2481460C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics
02/15/2011CA2470067C Imidazoquinoline derivatives
02/15/2011CA2452502C 2-(3,5-bis-trifluoromethyl-phenyl)-n-[6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-n-methyl-isobutyramide
02/15/2011CA2452445C Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
02/15/2011CA2446864C Inhibitors of src and other protein kinases
02/10/2011WO2011017165A1 Method of preventing renal disease and treating symptoms thereof
02/10/2011WO2011016472A1 Pyridine and pyrimidine derivatives having ttk-inhibiting activity
02/10/2011WO2011016459A1 Thienooxazepine derivative
02/10/2011US20110034547 Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof
02/10/2011US20110034534 siRNA compounds and methods of use thereof
02/10/2011US20110034527 Novel 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels
02/10/2011US20110034512 Indazole Compounds As CCR1 Receptor Antagonists
02/10/2011US20110034499 Spiroindolines as modulators of chemokine receptors
02/10/2011US20110034470 Inhibitors of JNK
02/10/2011US20110034458 Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors
02/10/2011US20110034426 Method of Preventing Renal Disease and Treating Symptoms Thereof
02/10/2011US20110034381 Methods for Therapeutic Treatment of Benign Prostatic Hypertrophy (BPH)
02/10/2011US20110034378 Pharmaceutical Combinations Comprising Specified Age Breaker and Further Drugs, I.A. Antihypertensive Drugs, Antidiabetic Drugs Etc.
02/10/2011US20110033535 Pharmaceutical composition as solid dosage form and method for manufacturing thereof
02/10/2011US20110033533 Galenical formulations of organic compounds
02/10/2011US20110033523 Use of microvesicles (mvs) derived from stem cells for preparing a medicament for endo/epithellal regeneration of damaged or injured tissues or organs, and related in vitro and in vivo methods
02/10/2011US20110033521 Molecules and Methods of Using Same for Treating MCP-1/CCR2 Associated Diseases
02/10/2011US20110033508 Injectable microspheres for dermal augmentation and tissue bulking
02/10/2011US20110033469 Leukotriene b4 binding soluble lipocalin receptor from ixodes ricinus
02/10/2011US20110033457 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
02/10/2011CA2764577A1 Method of preventing renal disease and treating symptoms thereof
02/09/2011EP2281823A2 Anti-inflammatory and analgesic piperidine derivatives
02/09/2011EP2281818A1 Fused pyridazine derivative compounds and drugs containing these compounds as the active ingredient
02/09/2011EP2281813A1 Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses
02/09/2011EP2281567A1 Inhibitor for blood phosphorus level elevation
02/09/2011EP2280948A1 Pyrimidine, pyridine and triazine derivatives as maxi-k channel openers.
02/09/2011EP2280928A2 Vinyl substituted fatty acids
02/09/2011EP2044946B1 Preventive remedial therapeutic agent for phosphorus impairment, oral agent for adsorbing phosphate ion contained in food, beverage and chemical, and process for producing them
02/09/2011EP1405638B1 Pharmaceutical composition comprising quinuclidin-3'-yl 1-phenyl-1,2,3,4,-tetrahydroisoquinoline-2-carboxylate for treatment of interstitial cystitis and/or abacterial prostatitis
02/09/2011EP1370276B1 Intercellular communication facilitating compounds and their medical use
02/09/2011CN1814011B Preparing method of injection for treating upper respiratory tract inflammation
02/09/2011CN1547464B Prolonged release bioadhesive therapeutic systems
02/09/2011CN101970442A Bicyclic pyrrole compound
02/09/2011CN101967439A Vine root health wine and preparation method thereof
02/09/2011CN101967146A Ep4 receptor inhibitors to treat rheumatoid arthritis
02/09/2011CN101966314A Traditional Chinese medicine preparation for tonifying kidney and replenishing sperm and preparation method thereof